Glucose monitors for diabetes have finally been funded – but there's a problem
There are problems within the health system that mean full patient access to training on how to use the insulin pumps will ...
Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits
To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...
Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor
Senseonics Holdings, Inc. (NYSE American: SENS) ("Senseonics" or the "Company"), a medical technology company focused on the ...
Armed robbery in Revesby1d
Glucose Monitors Funded, Workforce Shortage Looms
Pharmac's decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live ...
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with ...
Taiwan News9d
Continuous Glucose Monitoring Systems Market Insights, Advances in Diabetes Management, 2024 to 2032
The global continuous glucose monitoring systems (CGMS) market was valued at approximately USD 6,626.6 million in 2021 and is expected to grow to USD 31,708.2 million by 2032, with a CAGR of 17.0% ...
Abbott Q3: Strong Growth In Medical Device And Pharma
Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...
Non-Invasive Blood Glucose Monitoring Systems Market Size To Reach USD 101.1 Billion By 2032 Latest Research Report
GEORGIA AVENUE, WA, UNITED STATES, October 17, 2024 /EINPresswire / -- The latest release from Vantage <a target=_blank href= ...
Nasdaq13d
Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology
Abbott Laboratories (NYSE: ABT) has established a strong presence in diabetes management with its CGM system, FreeStyle Libre. Libre offers accurate and continuous glucose monitoring, but the ...